SSI Investment Management LLC Takes $6.09 Million Position in iShares Biotechnology ETF $IBB

SSI Investment Management LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 36,104 shares of the financial services provider’s stock, valued at approximately $6,093,000. SSI Investment Management LLC owned about 0.07% of iShares Biotechnology ETF as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Basepoint Wealth LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $26,000. Cary Street Partners Financial LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $29,000. Darwin Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Cornerstone Planning Group LLC purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $35,000. Finally, Copia Wealth Management purchased a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $172.18 on Friday. The firm has a 50 day moving average of $169.35 and a 200 day moving average of $170.34. iShares Biotechnology ETF has a twelve month low of $120.33 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.